Identification of potential genes regulated by DNA methyltransferase 3B in a hepatocellular carcinoma cell line by RNA interference and microarray analysis

Acta Genetica Sinica

Volumn 32, Issue 11, 2005, Pages 1115-1127

  Xu, Jun ^a   Fan, Hong ^a   Zhao, Zhu Jiang ^a   Zhang, Jian Qiong ^a   Xie, Wei ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

DNMT3B; Hepatocellular carcinoma; Methyltransferase; RNA interference

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; COMPLEMENTARY DNA; DNA METHYLTRANSFERASE 3B; METHYL CPG BINDING PROTEIN 3; NOTCH1 RECEPTOR; NUCLEIC ACID BINDING PROTEIN; PLASMID VECTOR; PROTEIN; PROTEIN FACL4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN; WNT11 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENZYME REPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA STABILITY; STATISTICAL SIGNIFICANCE; UNINDEXED SEQUENCE; UPREGULATION; WESTERN BLOTTING;

EID: 28644433852     PISSN: 03794172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Jones P A, Laird P W. Cancer epigenetics comes of age. Nature Genetics, 1999, 21(2): 163-167.
2. Feinberg A P,Gehrke C W, Kuo K C, Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res, 1988, 48(5): 1159-1161.
3. Cui J, Yang D H, Bi X J, Fan Z R. Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology. World J Gastroentero, 2001, 7(1): 136-139.
4. Baylin S B, Hoppener J W M, de Bustros A, Steenbergh P H, Lips C J M, Nelkin B D. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res, 1986, 46(6): 2917-2922.
5. Fang J Y, Lu J, Chen Y X, Yang L. Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines. World J Gastroenterol, 2003, 9(9): 1976-1980.
6. Merlo A, Herman J G, Mao L, Lee D J, Gabrielson E, Burger P C, Baylin S B, Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med, 1995, 1(7): 686-692.
7. Herman J G, Merlo A, Mao L, Lapidus R G, Issa J P J, Davidson N E, Sidransky D, Baylin S B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all human cancers. Cancer Res, 1995, 55(20): 4525-4530.
8. YANG Yu-Hua, HE Xiao-Bing, ZHANG Feng-Rui, ZHANG Jian-Qiong, XIE Wei. Relationship between CpG methylation of p16 gene and sporatic colorectal cancer. Acta Genetica Sinca, 2003, 30(11):1061-1064.
9. Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S. DNA methyltransferase expression and DNA methylation of CpG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer, 2001, 91 (2): 205-212.
10. Kim H, Kim Y H, Kim S E, Kim N G, Noh S H, Kim H. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. Journal of pathology, 2003, 200(1): 23-31.
11. Esteller M, Corn P G, Baylin S B, Herman J G. A gene hypermethylation profile of human cancer. Cancer Res, 2001, 61(8): 3225-3229.
12. Fournel M, Sapieha P, Beaulieu N, Besterman J M, MacLeod A R. Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21 (WAF/Cip1) by distinct mechanisms. J Biol Chem, 1999, 274(34): 24250-24256.
13. Bestor T H. The DNA methyltransferases of mammals. Hum Mol Genet, 2000, 9(16): 2395-2402.
14. Robertson K D. DNA methylation, methyltransferases and cancer. Oncogene, 2001, 20(24): 3139-3155.
15. Robertson K D. DNA methylation and chromatin-unraveling the tangled web. Oncogene, 2002, 21(35): 5361-5379.
16. Aapola U, Lyle R, Krohn K, Antonarakis S E, Peterson P. Isolation and initial characterization of the mouse Dnmt3l gene. Cytogenet Cell Genet, 2001, 92(1-2): 122-126.
17. Bourc'his D, Xu G L, Lin C S, Bollman B, Bestor T H. Dnmt3L and the establishment of maternal genomic imprints. Science, 2001, 294(5551): 2536-2539.
18. Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet, 1998, 19(3): 219-220
19. Robertson K D, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales F A, Jones P A. The human DNA methyltransferases (DNMTs) 1,3a and 3b:coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res, 1999, 27(11): 2291-2298.
20. Rhee I, Jair K W, Yen R W, Lengauer C, Herman J G, Kinzler K W, Vogelstein B, Baylin S B, Schuebel K E. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature, 2000, 404(6781): 1003-1007.
21. Rhee I, Bachman K E, Park B H, Jair K W, Yen R W, Schuebel K E, Cui H, Feinberg A P, Lengauer C, Kinzler K W, Baylin S B, Vogelstein B. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 2002, 416(6880): 552-556.
22. ZHANG Hong, XIAO Wen-Hua, LIANG Hou-Jie, FANG Dian-Chun, YANG Shi-Ming, LUO Yuan-Hui. Demethylation in the promoter area by the antisense of human DNA MTase gene. Chinese Journal of Oncology, 2002, 5(24): 444-447.
23. Baylin S B, Makos M, Wu J J, Yen R W, de Bustros A, Vertino P, Nelkin B D. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells, 1991, 3(10): 383-390.
24. Baylin S B, Herman J G, Graff J R, Vertino P M, Issa J P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res, 1998, 72: 141-196.
25. Ding Y, Le X P, Zhang Q X, Du P. Methylation and mutation analysis of p16 gene in gastric cancer. World J Gastroenterol, 2003, 9(3): 423-426.
26. Vertino P M, Yen R W, Gao J, Baylin S B. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)- methyltransferase. Mol Cell Biol, 1996, 16(8): 4555-4565.
27. Wu J, Issa J, Herman J, Bassett Jr D E, Nelkin B D, Baylin S B. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci USA, 1993, 90(19): 8891-8895.
28. Okano M, Bell D W, Haber D A, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 1999, 99 (3): 247-257.
29. Watanabe D, Suetake I, Tada T, Tajima S. Stage- and cell-specific expression of Dnmt3a and Dnmt3b during embryogenesis. Mech Dev, 2002, 118(1-2): 187-190.
30. Xu G L, Bestor, T H, Bourc'his D, Hsieh C L, Tommerup N, Bugge M, Hulten M, Qu X, Russo J J, Viegas-Pequignot E. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature, 1999, 402(6758): 187-191.
31. Hansen R S, Wijmenga C, Luo P, Stanek A M, Canfield T K, Weemaes C M, Gartler S M. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci USA, 1999, 96(25): 14412-14417.
32. Wu K, Weng Z, Tao Q, Lin G, Wu X, Qian H, Zhang Y, Ding X, Jiang Y, Shi Y E. Stage-specific expression of breast cancer-specific gene gamma-synuclein. Cancer Epidemiol Biomarkers Prev, 2003, 12(9): 920-925.
33. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 1991, 251(5000): 1451-1455.
34. Gupta A, Godwin A K, Vanderveer L, Lu A, Liu J. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res, 2003, 63(3): 664-673.
35. Yanagawa N, Tamura G, Honda T, Endoh M, Nishizuka S, Motoyama T. Demethylation of the synuclein gamma gene CpG islands in primary gastric cancers and gastric cancer cell lines. Clin Cancer Res, 2004, 10(7): 2447-2451.
36. Ouko L, Ziegler T R, Gu L H, Eisenberg L M, Yang V W. Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells. J Biol Chem, 2004, 279(25): 26707-26715.
37. Sung Y K, Hwang S Y, Park M K, Bae H I, Kim W H, Kim J C, Kim M. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma. Cancer Sci, 2003, 94(5): 421-424.
38. Aoki A, Suetake I, Miyagawa J, Fujio T, Chijiwa T, Sasaki H, Tajima S. Enzymatic properties of de novo-type mouse DNA (cytosine-5) methyltransferases. Nucleic Acids Res, 2001, 29(17): 3506-3512.
39. Gowher H, Jeltsch A. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG sites. J Mol Biol, 2001, 309(5): 1201-1208.
40. Yokochi T, Robertson K D. Preferential methylation of unmethylated DNA by mammalian de novo DNA methyltransferase Dnmt3a. J Biol Chem, 2002, 277(14): 11735-11745.
41. Gaudet F, Hodgson J G, Eden A, Jackson-Grusby L, Dausman J, Gray J W, Leonhardt H, Jaenisch R. Induction of tumors in mice by genomic hypemetylation. Science, 2003, 300(5618): 489-492.